How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Lung Function Test Calibration Gas Market
- By Gas Composition: Nitric Oxide Calibration Gas, Carbon Monoxide Calibration Gas, Oxygen Calibration Gas, Carbon Dioxide Calibration Gas, Methane Calibration Gas
- By Form Factor: Compressed Gas Cylinders, Gas Mixtures in Cylinders, Gas Mixtures in Bags, Gas Mixtures in Canisters
- By End-User: Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutions, Pulmonary Function Testing Centers
- By Calibration Gas Purity Grade: Medical Grade, Analytical Grade, Industrial Grade
- By Application: Spirometry Calibration, Gas Analyzer Calibration, Respiratory Equipment Calibration
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Nitric Oxide Calibration Gas leads By Gas Composition at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.176 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.184 →
Full report · locked preview
Everything inside the Lung Function Test Calibration Gas Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Air Liquide
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Linde plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Air Products and Chemicals Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Matheson Tri-Gas Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Praxair Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Messer Group GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Taiyo Nippon Sanso Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →BOC Group Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Scott Specialty Gases
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Airgas Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Nippon Gases Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Messer Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Air Water Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Air Liquide Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Nitric Oxide Calibration Gas54.8
- Carbon Monoxide Calibration Gas11.1
- Oxygen Calibration Gas11.2
- Carbon Dioxide Calibration Gas11.4
- Methane Calibration Gas11.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Air Liquide17.9
- Linde plc18.2
- Air Products and Chemicals Inc.11.4
- Matheson Tri-Gas Inc.12.1
- Praxair Inc.5.6
- Messer Group GmbH6.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.1
- Europe20.9
- Asia Pacific20.6
- Latin America14.3
- Middle East and Africa9.1
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Air Liquide | 89 | 89 | 75 | 89 | 94 | 93 | 88 |
| Linde plc | 72 | 84 | 91 | 73 | 89 | 84 | 82 |
| Air Products and Chemicals Inc. | 73 | 73 | 72 | 80 | 88 | 83 | 78 |
| Matheson Tri-Gas Inc. | 74 | 78 | 80 | 62 | 61 | 64 | 70 |
| Praxair Inc. | 76 | 76 | 57 | 71 | 51 | 71 | 67 |
| Messer Group GmbH | 66 | 66 | 55 | 65 | 65 | 64 | 64 |
| Taiyo Nippon Sanso Corporation | 41 | 48 | 55 | 45 | 56 | 53 | 50 |
| BOC Group Limited | 43 | 39 | 37 | 54 | 48 | 44 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Air Liquide
- Linde plc
- Air Products and Chemicals Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Air Liquide | ◐ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Linde plc | ◐ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Air Products and Chemicals Inc. | ◐ | ◐ | − | ✓ | ◐ | ◐ |
| Matheson Tri-Gas Inc. | ◐ | ✓ | ✓ | ✓ | − | ◐ |
| Praxair Inc. | ◐ | ✓ | ◐ | ◐ | − | ◐ |
| Messer Group GmbH | ◐ | − | ◐ | ◐ | ✓ | ◐ |
| Taiyo Nippon Sanso Corporation | − | ◐ | ◐ | − | ◐ | ◐ |
| BOC Group Limited | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender1
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Gas Composition in North America, then scale across Lung Function Test Calibration Gas Market — a $158M beachhead inside a $2.47B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Nitric Oxide Calibration Gas
Best fit — highest urgency & budget in Gas Composition.
Carbon Monoxide Calibration Gas
Strong fit — clear ROI and a fast path to value.
Oxygen Calibration Gas
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Gas Composition in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form Factor & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Gas Composition leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Lung Function Test Calibration Gas Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Lung Function Test Calibration Gas Market is a durable-growth opportunity — $7.14B by 2033, compounding at 8.6%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.6% CAGR
Demand compounds through 2033, outpacing GDP across Gas Composition.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Gas Composition moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form Factor optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Lung Function Test Calibration Gas Market — a $10.9B market by 2033. Plan: grow share from 5.7% to 12.6%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.7% | 12.6% | Ahead |
| Revenue | $677M | $1.38B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 36.2% | 39.8% | Ahead |
| Customer retention | 87.2% | 92.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Gas Composition
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Form Factor capability
A defensible second engine — invest in Form Factor to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Gas Composition share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form Factor
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $193M capacity & capability investment
- Greenlight bolt-on M&A in Form Factor
- Authorise North America expansion plan
- Fund R&D program for Gas Composition leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentAt risk
Sales deck · value proposition
Win the Lung Function Test Calibration Gas Market conversation — a $2.16B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Gas Composition
Goal Grow share in Gas Composition
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Lung Function Test Calibration Gas Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Lung Function Test Calibration Gas Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Lung Function Monitor Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportLung Exercise Machine Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportLung Disease Therapeutics Market
Market size, share, segmentation and regional forecast.
$302M market · 2025 base year
View reportLung Disease Therapeutic Drug Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportLung Demonstration Models Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportLung Cancer Vaccine Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportLung Cancer Treatment Software Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportLung Cancer Test Kit Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportLung Cancer Surgery Equipment Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportLung Cancer Screening Software Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportLung Cancer Genomic Testing Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportLung Cancer Diagnostics Kit Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy